Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ruxolitinib Response in an Infant With Very-early-onset Inflammatory Bowel Disease and Gain-of-function STAT1 Mutation.

Journal of pediatric gastroenterology and nutrition - 1 Oct 2020

Acker Karen P, Borlack Rachel, Iuga Alina, Remotti Helen E, Soderquist Craig R, Okada Satoshi, Tsumura Miyuki, Casanova Jean-Laurent, Picoraro Joseph, Puel Anne, Kinberg Sivan, Demirdag Yesim

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gain of Function Mutation
Share to Infant
Share to Inflammatory Bowel Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Nitriles

Share to Pyrazoles

Share to Pyrimidines

Share to STAT1 Transcription Factor

Source

Identifiers

PMID: 32732635
DOI: 10.1097/MPG.0000000000002854

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ruxolitinib Response in an Infant With Very-early-onset Inflammatory Bowel Disease and Gain-of-function STAT1 Mutation.PMID 32732635Read ↗

Ruxolitinib: Targeted Approach for Treatment of Autoinflammatory Very Early Onset Inflammatory Bowel Disease.Semantic proximity Read ↗

Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain-of-Function (GOF) Mutations – 10 Children and Review of the LiteratureSemantic proximity Read ↗

Efficacy of Ruxolitinib Therapy in a Patient With Severe Enterocolitis Associated With a STAT3 Gain-of-Function MutationSemantic proximity Read ↗

Gain-of-function of MEFV Mutation Causes Very Early Onset Inflammatory Bowel Disease.Semantic proximity Read ↗

Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations—10 Children and Review of the LiteratureSemantic proximity Read ↗

SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance?Semantic proximity Read ↗

Commentary on Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early-onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey.Semantic proximity Read ↗

Matched Unrelated Donor Hematopoietic Stem Cell Transplant as Successful Curative Therapy for IL10RB Mutation-Associated Very Early Onset IBD.Semantic proximity Read ↗

IBD LIVE Case Series--Case 3: Very Early-Onset Inflammatory Bowel Disease: When Genetic Testing Proves Beneficial.Semantic proximity Read ↗

Molecular diagnosis of infantile onset inflammatory bowel disease by exome sequencing.Semantic proximity Read ↗

Failure to thrive: A severe manifestation of interleukin 10 receptor A mutation in adult inflammatory bowel disease.Semantic proximity Read ↗

Clinical phenotypes and genotypic characteristics of infantile-onset inflammatory bowel disease with interleukin-10 receptor A mutations in 22 Chinese childrenSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.